Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
811.08
-12.15 (-1.48%)
Jan 31, 2025, 4:00 PM EST - Market closed
Eli Lilly Market Cap
Eli Lilly has a market cap or net worth of $730.32 billion as of January 31, 2025. Its market cap has increased by 22.33% in one year.
Market Cap
730.32B
Enterprise Value
757.48B
1-Year Change
22.33%
Ranking
Category
Stock Price
$811.08
Market Cap Chart
Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $730.32B, an increase of 635.86%. That is a compound annual growth rate of 7.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 31, 2025 | 769.97B | 5.06% |
Dec 31, 2024 | 732.87B | 32.44% |
Dec 29, 2023 | 553.37B | 59.19% |
Dec 30, 2022 | 347.61B | 31.56% |
Dec 31, 2021 | 264.23B | 63.60% |
Dec 31, 2020 | 161.51B | 27.99% |
Dec 31, 2019 | 126.19B | 2.94% |
Dec 31, 2018 | 122.58B | 31.81% |
Dec 29, 2017 | 93.00B | 14.54% |
Dec 30, 2016 | 81.20B | -13.04% |
Dec 31, 2015 | 93.37B | 21.55% |
Dec 31, 2014 | 76.82B | 33.69% |
Dec 31, 2013 | 57.46B | 0.39% |
Dec 31, 2012 | 57.23B | 18.95% |
Dec 30, 2011 | 48.12B | 19.08% |
Dec 31, 2010 | 40.41B | -1.52% |
Dec 31, 2009 | 41.03B | -10.38% |
Dec 31, 2008 | 45.79B | -24.40% |
Dec 31, 2007 | 60.56B | 2.72% |
Dec 29, 2006 | 58.96B | -8.34% |
Dec 30, 2005 | 64.32B | 0.16% |
Dec 31, 2004 | 64.22B | -18.68% |
Dec 31, 2003 | 78.97B | 10.71% |
Dec 31, 2002 | 71.33B | -19.21% |
Dec 31, 2001 | 88.30B | -15.83% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UnitedHealth Group | 500.34B |
Novo Nordisk | 376.62B |
Johnson & Johnson | 370.15B |
AbbVie | 310.84B |
Merck & Co. | 250.76B |
Thermo Fisher Scientific | 232.12B |
Abbott Laboratories | 223.77B |
AstraZeneca | 218.67B |